Cytek Biosciences
CTKB
CTKB
101 hedge funds and large institutions have $658M invested in Cytek Biosciences in 2023 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
1.59%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
24
Increased
51
Reduced
18
Closed
25
Calls
$1.51M
Puts
$36K
Net Calls
+$1.47M
Net Calls Change
+$543K
Top Buyers
| 1 |
BlackRock
New York
|
$129M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$90.7M |
| 3 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
$91.6M |
| 4 |
State Street
Boston,
Massachusetts
|
$29.1M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
$4.07M |
